Filter News
Area of Research
- (-) Biology and Environment (15)
- (-) Neutron Science (23)
- (-) Nuclear Science and Technology (3)
- Biological Systems (1)
- Clean Energy (21)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (2)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (37)
- Materials for Computing (7)
- National Security (7)
- Supercomputing (23)
News Type
News Topics
- (-) Biomedical (16)
- (-) Coronavirus (13)
- (-) Materials Science (16)
- (-) Polymers (2)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (5)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (15)
- Biology (19)
- Biotechnology (5)
- Chemical Sciences (4)
- Clean Water (5)
- Climate Change (3)
- Composites (1)
- Computer Science (20)
- Decarbonization (2)
- Energy Storage (4)
- Environment (27)
- Exascale Computing (1)
- Fusion (8)
- High-Performance Computing (6)
- Isotopes (3)
- Machine Learning (3)
- Materials (5)
- Mathematics (1)
- Mercury (4)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (10)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (20)
- Physics (6)
- Quantum Computing (1)
- Quantum Science (4)
- Space Exploration (3)
- Summit (10)
- Sustainable Energy (10)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Two scientists with the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Physical Society.